Stay updated on LY3454738 in Chronic Urticaria - Clinical Trial
Sign up to get notified when there's something new on the LY3454738 in Chronic Urticaria - Clinical Trial page.

Latest updates to the LY3454738 in Chronic Urticaria - Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo significant changes detected between the screenshots; core study details such as title, conditions, design, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedUpgrade to v3.2.0 is introduced, replacing v3.1.0, plus a government-operating-status notice. This signals a status check for current operations but does not modify concrete content like pricing or stock.SummaryDifference3%

- Check45 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a prior revision note (Revision: v3.0.2).SummaryDifference0.5%

- Check59 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations across the United States and Europe, as well as new content related to drug safety and counterfeit drugs.SummaryDifference4%

Stay in the know with updates to LY3454738 in Chronic Urticaria - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3454738 in Chronic Urticaria - Clinical Trial page.